The document is one of the early fruits of GA4GH Connect, a five-year initiative to better align the group's objectives with the key needs of the international genomic data community.
WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.
Centogene opened a Boston office in December and plans to open a lab there in a few months as it awaits an FDA decision on its clinical tool.
The clinicals labs contributing to the database are adding more case-level data and focusing on outlier interpretations.
CureOne also received CMS's approval for 11 quality metrics around biomarker testing that doctors can report for MIPS-related payment.
The partners will collect and analyze cancer samples and analyze data to support basic and translational research and advance precision oncology and personalized medicine.
The newly launched Luna DNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.
The creator of the Genome Aggregation Database sees an ever-expanding GnomAD database as a centerpiece to improving the diagnosis of rare diseases.
Payors' demands for clinical utility evidence can be met through greater use of databases and registries, Harold Varmus and Rebecca Eisenberg said.
LifeOmic will use Genomenon's Mastermind technology to tag disease-causing variants with citations from the applicable literature.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.